Drug intelligence / Profile preview

Lacorwen-S

Development stage
Unknown
Lead developer
Weber & Weber
Modality
Small Molecules
Administration
Oral
01

Overview

Lacorwen-S is a natural homeopathic medicinal product developed by Weber & Weber Biologische Arzneimittel, specifically formulated to address nervous heart complaints and functional cardiovascular disturbances. The preparation is a combination of several active ingredients, including Crataegus (Hawthorn), Selenicereus grandiflorus (Night-blooming cereus), Spigelia anthelmia (Pinkroot), and Kalium carbonicum (Potassium carbonate). Crataegus is well-regarded in phytotherapy for its cardiotonic properties, believed to enhance coronary blood flow and myocardial contractility, potentially through the inhibition of 3',5'-cyclic-nucleotide phosphodiesterases. Selenicereus grandiflorus and Spigelia anthelmia are traditionally used in homeopathic medicine to manage symptoms such as heart palpitations, chest tightness, and irregular rhythms associated with nervous exhaustion. As an approved medicine in Germany, Lacorwen-S is typically administered as oral drops to support cardiac efficiency and alleviate symptoms of autonomic cardiac regulation disorders.

Brand names
Lacorwen-SLacorwen
02

Targets

PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on Lacorwen-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lacorwen-S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call